Shots:

• Theramax acquires commercialization rights of Zoely- allowing it to commercialize the therapy in 50+ countries globally. Earlier- Theramax has right to commercialize Zoely in eleven countries in the EU while MSD retains rights in the US and Canada
• The acquisition of further rights of Zoely expands Theramex global footprints by providing innovative therapies to maintain the healthcare of women
• Zoely is a combined oral contraceptive therapy consisting of two steroid hormones; 17-beta estradiol and nomegestrol acetate

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Theramex